Tenofovir Disoproxil Fumarate: Clinical Pharmacology and Pharmacokinetics

Author： Kearney B.P.   Flaherty J.F.   Shah J.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.43, Iss.9, 2004-01, pp. : 595-612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tenofovir Disoproxil Fumarate in the Clinical Practice: An Overview

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 4, 2008-10 ,pp. : 285-295

Bentham Science Publishers

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 160-161

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Toni M. Dando   Antona J. Wagstaff  

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2075-2082

Adis International

Access to resources Recommend Favorite

Tenofovir Disoproxil Fumarate

By Chapman T.M.   McGavin J.K.   Noble S.  

Drugs, Vol. 63, Iss. 15, 2003-01 ,pp. : 1597-1608

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

By Kearney Brian P.   Yale Kitty   Shah Jaymin   Zhong Lijie   Flaherty John F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1115-1124

Adis International

Access to resources Recommend Favorite